Contrast-Induced Nephropathy: Pathophysiology, Prevention, and Monitoring
*Corresponding Author: Dr. Hamza Idrissi, Department of Clinical Radiology, Fez Medical University, Morocco, Email: h.idrissi@cinrad.maReceived Date: Aug 05, 2025 / Published Date: Aug 29, 2025
Citation: Idrissi DH (2025) Contrast-Induced Nephropathy: Pathophysiology, Prevention, and Monitoring. J Radiol 14: 724.DOI: 10.4172/2167-7964.1000724
Copyright: 2025 Dr. Hamza Idrissi This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited
Abstract
Contrast-induced nephropathy (CIN) remains a critical clinical issue, with ongoing research exploring its pathophysiology, risk factors, and prevention strategies. Recent advancements focus on oxidative stress, inflammation, and hemodynamic changes, alongside identifying high-risk patients. Current management emphasizes risk stratification, hydration, and judicious contrast agent use. Long-term outcomes and novel biomarkers are also areas of active investigation. Comparative studies on contrast media nephrotoxicity and tailored approaches for specific procedures are further refining preventive measures.
